drugset / Trial / NCT00720473

Lamotrigine Therapy in Geriatric Bipolar Depression

NCT00720473

Completed 69 enrolled Mclean Hospital
Non-randomizedParallel-groupOpen-labelBasic science

Summary

We propose to study the efficacy and tolerability of lamotrigine in the treatment of older adults with bipolar depression and to compare measures of brain energy metabolism between older subjects with bipolar depression and healthy age-matched controls in order to better understand treatment response in geriatric bipolar depression.

Timeline

Start
2006-04
Primary completion
2011-07
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Lamotrigine Small molecule 25 mg
Subject Lamotrigine Small molecule 200 mg

Indications